VBIV Projected Dividend Yield
VBI Vaccines Inc (Canada) ( OTCBB : VBIV )VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Co. develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. Co. is focused on targeting and overcoming significant infectious diseases, including hepatitis B (HBV), coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). 21 YEAR PERFORMANCE RESULTS |
VBIV Dividend History Detail VBIV Dividend News VBIV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |